Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Teva – Recall of Idarubicin injection
March 29, 2022 - Teva announced a user-level recall of one lot of idarubicin injection because of particulate matter, identified as silica and iron oxide, found in one vial.
